Skip to main content
Fig. 3 | BMC Pharmacology and Toxicology

Fig. 3

From: Immuno-oncological effects of standard anticancer agents and commonly used concomitant drugs: an in vitro assessment

Fig. 3

Evaluation of standard anticancer agents. (a-b) Bliss scores calculated after treatment with the validation drug panel and dexamethasone at 1µM for 72 h in HCT116-GFP (a) and A549-NLR (b). Data shown as mean ± SEM from three independent experiments. (c-d) Bliss scores (x-axis) plotted against the viability in PBMC monocultures (y-axis) after treatment with the validation drug panel at 1µM for 72 h in HCT116-GFP (c) and A549-NLR (d). Data shown as means from three independent experiments

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us